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ABSTRACT
Recent reports have demonstrated that most biofilms involved in catheter-associated urinary tract
infections are polymicrobial communities, with pathogenic microorganisms (e.g. Escherichia coli,
Pseudomonas aeruginosa, Klebsiella pneumoniae) and uncommon microorganisms (e.g. Delftia tsur-
uhatensis, Achromobacter xylosoxidans) frequently co-inhabiting the same urinary catheter.
However, little is known about the interactions that occur between different microorganisms and
how they impact biofilm formation and infection outcome. This lack of knowledge affects CAUTIs
management as uncommon bacteria action can, for instance, influence the rate at which patho-
gens adhere and grow, as well as affect the overall biofilm resistance to antibiotics. Another rele-
vant aspect is the understanding of factors that drive a single pathogenic bacterium to become
prevalent in a polymicrobial community and subsequently cause infection. In this review, a gen-
eral overview about the IMDs-associated biofilm infections is provided, with an emphasis on the
pathophysiology and the microbiome composition of CAUTIs. Based on the available literature, it
is clear that more research about the microbiome interaction, mechanisms of biofilm formation
and of antimicrobial tolerance of the polymicrobial consortium are required to better understand
and treat these infections.
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The microorganisms found in diverse environments,
including aquatic, soil, industrial and clinical settings, are
able to alter their state between a planktonic and sessile
mode of life. Typically, more than 90% of them live in
the sessile state, which is induced when microorganisms
are exposed to changing environmental conditions
(Costerton et al., 1987). This can result in a microbial
community, known as a microbial biofilm, that involves
one or more species of microorganisms adhered to an
inert or living surface, enclosed in an extracellular poly-
meric substance (EPS) matrix containing nucleic acids,
proteins and polysaccharides (Costerton et al., 1999;
Davey & O'Toole, 2000). The ecological advantages of
microorganisms in forming biofilms include protection
from hostile environmental conditions (e.g. pH, chemical
exposure, radiation and phagocytosis), acquisition of
biofilm-specific antibiotic-resistant phenotypes and
expanded metabolic cooperation (Costerton et al., 1987;
Davey & O'Toole, 2000). In addition, individual cells
embedded in microbial biofilms display an altered
phenotype, which is associated with a reduced growth
rate, higher tolerance to antimicrobial agents or to host
defenses, altered expression of specific genes and secre-
tion of molecules and virulence factors (Costerton et al.,
1987; Donlan, 2002; Donlan & Costerton, 2002; Hall-
Stoodley & Stoodley, 2009; Stewart & Franklin, 2008).
Microbial biofilms play an important role in about
80% of human microbial infections (Davies, 2003;
R€omling & Balsalobre, 2012). Common human infectious
diseases involving biofilm formation in body tissues
include chronic airway infections in cystic fibrosis
patients (Høiby et al., 2010), chronic otitis (Wessman
et al., 2015), chronic sinusitis (Jain & Douglas, 2014),
chronic (diabetes) wound infection (James et al., 2008),
periodontitis (Socransky et al., 1998) and urinary tract
infection (UTI) (Soto et al., 2006). In addition, due to
recent advances in medical science, indwelling medical
devices (IMDs) have been widely used in hospitals. Their
use may result in IMD-related infections involving bio-
films (Wu et al., 2015), a situation that has been
described for intravenous catheters (Smith & Nolan,
2013), prosthetic heart valves (Murdoch et al., 2009),
urinary catheters (Hola et al., 2010), orthopedic devices
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(Campoccia et al., 2006), cardiac pacemakers (Inacio
et al., 2015), intrauterine devices (Auler et al., 2010), bil-
iary tract stents (Schneider et al., 2014), breast implants
(Karau et al., 2013), contact lenses (Willcox, 2007) and
voice prosthesis (van der Mei et al., 2014).
The surface of IMDs offers a favorable environment
for the colonization and growth of a large number of
microorganisms, with a predominance of Gram-negative
and Gram-positive bacterial species, as shown in Table 1.
The source of these microorganisms might be the skin of
hospitalized patients or health-care workers and the hos-
pital environment (Pr€uss et al., 1999).
IMDs-associated biofilm infections have a great
impact in public health. For instance, higher healthcare
costs are related with these infections (Donlan, 2001),
due to the prolonged stay in hospitals and the contin-
ued use of antimicrobials. Another worrying feature is
that these types of infections are difficult to eradicate,
due to the presence of polymicrobial communities
involving multi-drug resistant pathogens (Francolini &
Donelli, 2010). In fact, polymicrobial biofilms are in gen-
eral more resistant to antibiotic treatment than the cor-
responding single-species biofilms (Al-Bakri et al., 2005;
Burmølle et al., 2006; Kara et al., 2006; Leriche et al.,
2003) and corresponding planktonic cells (Ceri et al.,
1999). In most cases, the only way to treat them is
through the removal or substitution of the IMD
(Donlan, 2001).
Catheter-associated urinary tract infections
The European Center for Disease Prevention and Control
reported that, annually, approximately 4.1 million
patients are estimated to acquire a nosocomial infection
(infections acquired in hospitals and other healthcare
facilities) in European hospitals (Wolfe et al., 2012).
Among these infections, UTIs are a frequent nosocomial
infection (Stamm & Norrby, 2001). The major risk factor
for UTIs is the use of urinary catheters. It was reported
that about 70–80% of nosocomial infections are related
with its use (Lo et al., 2014; Zarb et al., 2012).
The urinary catheter is inserted in patients through
the urethra and into the bladder, in order to measure
the urine output and to prevent/control urine retention
or incontinence (Hall-Stoodley et al., 2004; Warren,
2001). Despite careful aseptic management, the risk of
developing catheter-associated urinary tract infections
(CAUTI) increases 3–7% with each day of catheterization
(Hooton, 2010). This risk is higher for women, older
patients and diabetic patients (Hooton, 2010). It was
estimated that approximately $3790 is the minimum
amount spent in the treatment and diagnostic of each
episode of CAUTI (Friedman, 2014), including antimicro-
bial therapy, increased length of hospitalization,
physician visits and morbidity. In addition, it has
been reported that patients with CAUTIs might develop
other complications such as cystitis, pyelonephritis,
Gram-negative bacteremia, prostatitis, epididymitis, endo-
carditis, vertebral osteomyelitis, septic arthritis, endoph-
thalmitis and meningitis (Denstedt et al., 2000).
The presence of microbial biofilms on the surface of
urinary catheters removed from patients has long been
documented (e.g. Ganderton et al., 1992). In fact, the
replication of microorganisms in the presence of a con-
tinuous or intermittent flow of a warm nutritious
medium such as urine plays a crucial role on the
Table 1. Microorganisms commonly found in indwelling medical devices-associated biofilm infections.
Indwelling medical devices Prevalent causative microorganisms Refs.
Urinary catheters Escherichia coli, Proteus mirabilis, Enterococcus fae-
calis, Klebsiella pneumoniae, Pseudomonas
aeruginosa
Hola et al., 2010; Hooton, 2010; Nicolle, 2005
Central venous catheter Coagulase-negative staphylococcus, Staphylococcus
aureus, Enterococcus faecalis, P. aeruginosa,
Candida albicans, K. pneumoniae
Costerton et al., 1999; Lynch & Robertson, 2008;
Smith & Nolan, 2013
Prosthetic heart valve S. aureus, Streptococcus sp., coagulase-negative
staphylococcus, Enterococcus sp.
Lynch & Robertson, 2008; Murdoch et al., 2009
Orthopedic prosthesis Staphylococci, Streptococcus sp., Staphylococcus
pneumoniae
Campoccia et al., 2006; Costerton et al., 1999;
Lynch & Robertson, 2008
Contact lenses P. aeruginosa, S. aureus, Staphylococcus epidermidis,
E. coli, Proteus sp., Candida sp.
Costerton et al., 1999; Lynch & Robertson, 2008;
Sankaridurg et al., 2000; Willcox, 2007
Intrauterine devices S. epidermidis, S. aureus, C. albicans, Micrococcus
sp., Lactobacillus plantarum, Enterococcus sp.,
Prevotella sp., E. coli
Auler et al., 2010; Lynch & Robertson, 2008; Pal
et al., 2005
Voice prosthesis C. albicans, Candida tropicalis, Candida glabrata, S.
epidermidis, Streptococcus salivarius, P. aerugi-
nosa, K. pneumoniae, S. aureus, Klebsiella oxytoca
Kania et al., 2010; Sayed et al., 2012; Ticac et al.,
2010; van der Mei et al.,2014
Cardiac pacemakers Coagulase-negative staphylococcus, Streptococcus
sp., S. aureus, S. epidermidis
Chu et al., 2015; Inacio et al., 2015; Oliva et al.,
2013
Biliary tract stents Enterococcus sp., E. coli, Klebsiella sp., Clostridium
sp., Streptococcus sp., Candida sp.
Basioukas et al., 2014; Donelli et al., 2007;
Schneider et al., 2014
Breast implants E. coli, S. epidermidis, Propionibacterium acne,
coagulase-negative staphylococcus
Del Pozo et al., 2009; Karau et al., 2013; Lynch &
Robertson, 2008; Rieger et al., 2013
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establishment and development of a biofilm commu-
nity on the surface of urinary catheters (Tenke et al.,
2006). Additionally, the lumen of the urinary catheters is
characterized by the absence of inherent defense mech-
anisms, which makes the microorganism less prone, for
example, to detachment by the urine flow, to phagocyt-
osis and to the action of antimicrobials agents (Trautner
& Darouiche, 2004). Also, the normal defenses of the
bladder might be weakened when the urinary catheter
is used (Warren, 2001).
The recent use of advanced molecular technologies
has revealed the polymicrobial nature of UTIs/CAUTIs
(Fouts et al., 2012; Frank et al., 2009; Lewis et al., 2013;
Wolfe et al., 2012). The microbial communities in CAUTIs
can be shaped according to the host immune defenses
of the patient, prophylaxis measures and administrated
antibiotics. The way different microorganisms involved
in a polymicrobial community interact (synergistically or
antagonistically) will also have an impact on the micro-
bial diversity, virulence and response to therapy.
Pathogenesis of uropathogenic biofilms
As demonstrated in Figure 1(a), CAUTIs can develop in
several ways. After the insertion of the urinary catheter,
some urine components (proteins and other organic
molecules, including magnesium and calcium ions)
form a conditioning film along the urinary catheter sur-
face. Such phenomenon alters the characteristics of the
catheter surface and allows the adhesion of uropatho-
genic microorganisms (microorganisms that colonize,
persist and cause infection in the urinary tract) (Hatt &
Rather, 2008). The planktonic microorganisms adhere to
the surface either by physical forces (e.g. van der Waals
forces) or by specific adhesion molecules such as adhe-
sins (Gupta et al., 2016; Maric & Vranes, 2007) (Figure
1(bI, II)). Flagella and pili are also well-known virulence
factors, expressed by uropathogenic microorganisms,
which help the initial attachment of microorganisms to
the uroepithelial cells and to the urinary catheter sur-
face (Flores-Mireles et al., 2015; Nicolle, 2014b; O'Toole
& Kolter, 1998). Then, reversely attached microbial cells
become strongly adhered to the surface (irreversible
attachment) (Hall-Stoodley et al., 2004). In the next
stage, microorganisms firmly attached to the urinary
catheter surface interact with each other (Gupta et al.,
2016) and start to produce EPS (Busscher et al., 2008;
Jacobsen et al., 2008; Tenke et al., 2006) (Figure 1(bIII)).
EPS is mainly constituted by polysaccharides, proteins,
lipids and nucleic acids (DNA and RNA); EPS protects
the microorganisms within the biofilm, favoring the
mechanical stability of the biofilm and the adhesion of
the microorganisms to the surface (Flemming &
Wingender, 2010) (Figure 1(bIII)). The constant replica-
tion of microorganisms and EPS production results in
the formation of three-dimensional structures with
channels between them that are filled with urine and
enable the transport of essential nutrients and oxygen
to the microbial community (Denstedt et al., 2000;
Jacobsen et al., 2008; Tenke et al., 2006) (Figure 1(bIV)).
Lastly, microorganisms present within the biofilm
community firmly adhered to the surface of urinary
catheter can detach and return to the planktonic form
(Hall-Stoodley et al., 2004). At this stage, some microor-
ganisms are able to produce enzymes that destabilize
and breakdown the biofilm matrix; for example, E. coli
produces N-acetyl-heparosan lyase (Sutherland, 1999). If
these microorganisms are able to move against the
urine flow, they may colonize other sites of the urinary
tract such as the bladder and the kidneys, and may
even reach the bloodstream (Figure 1(bIV)) (Jacobsen
et al., 2008; Tenke et al., 2006).
Once a mature biofilm is formed, the uropathogenic
microorganisms have to further adapt to the conditions
found in the urinary tract environment. This can be
accomplished by the expression of genes responsible
for the capsular polysaccharide and lipopolysaccharide
synthesis, iron acquisition systems, antibiotics resistance
mechanisms, nitrogen and oxygen levels adaptation
(Snyder et al., 2004), and toxins production (e.g. hemo-
lysins and cytotoxic necrotizing factor 1) (Jacobsen
et al., 2008).
Nitrogen, iron and amino acids are essential nutrients
for the survival of uropathogens during CAUTI develop-
ment (Alteri et al., 2009; Subashchandrabose & Mobley,
2015). However, iron concentration in urine is too low
(Jacobsen et al., 2008; Shand et al., 1985). To overcome
this, uropathogens are able to upregulate genes encod-
ing molecules capable of recruiting the iron, called side-
rophores (Demir & Kaleli , 2004; Snyder et al., 2004).
Consequently, the survival and growth of the uropatho-
genic microorganisms during CAUTIs development,
even at low iron concentrations, might be guaranteed
when these microorganisms produce high concentra-
tions of siderophores, or at least, when they are able to
use the siderophores produced by neighboring microor-
ganisms (Jacobsen et al., 2008; Shand et al., 1985).
In addition, some bacteria, including P. mirabilis,
Proteus vulgaris or Providencia rettger, convert urea,
found at high concentrations in urine, to ammonia and
carbon dioxide through the use of the urease enzyme
(Donlan & Costerton 2002; Jacobsen et al., 2008). As an
alternative, microorganisms such as the urease-negative
E. coli use glutamine synthetase, an enzyme involved in
glutamine synthesis and in ammonia metabolism
(Hagan et al., 2010; Snyder et al., 2004). As a result of
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urea conversion into ammonia and carbon dioxide, the
pH of the local environment becomes alkaline, which
causes the precipitation of some minerals present in the
urine, including calcium phosphate and magnesium
ammonium phosphate (Broomfield et al., 2009; Stickler,
2014). This represents a frequent problem associated
with the formation of crystalline biofilms (as repre-
sented in Figure 1), which may have severe consequen-
ces, including trauma of the bladder and the urethral
epithelia. Also, the deposition of the crystalline material
on the surface of urinary catheters is frequently respon-
sible for the blockage of the urine flow (Hatt & Rather,
2008; Stickler, 2008; Tenke et al., 2006).
The microbiome diversity: traditional and
uncommon microorganisms
In short-term catheterization (up to 7 days), the urinary
catheter is frequently colonized by a single species. In
long-term catheterization, the catheter is placed for
Figure 1. Pathogenesis of biofilm formation on urinary catheters during catheter-associated urinary tract infections development.
(a) Catheter-associated urinary tract infections can develop in several ways: i) microorganisms present in the urethra, periurethral
skin or endogenous intestinal flora can migrate around the catheter extraluminally; ii) microorganisms can grow in the interior of
the drainage bag and ascend intraluminally through of the urinary catheter; iii) environmental and common skin microorganisms
can be directly introduced at the time of the catheter insertion due to inadequately decontaminated equipment or improper prac-
tices of the healthcare workers (Stamm, 1991; Tambyah et al., 1999); (b) Concerning CAUTIs, the first step involved in the forma-
tion of a catheter-associated biofilm is the deposition of a conditioning film on the surface of the urinary catheter, which
facilitates the binding of microorganisms (I, II). The next step involves the division of microorganisms and EPS production (III).
Consequently, a mature biofilm with a 3-dimensional structure is formed, with spaces between the aggregates that are filled with
fluid (urine). Finally, microorganisms or aggregates of these microorganisms can detach from the mature biofilm, colonizing other
sites (IV).
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several weeks and months and, in this case, a polymi-
crobial infection is inevitable (Jacobsen et al., 2008;
Nicolle, 2001; Warren, 1991, 2001), with a predominance
of Gram-negative bacteria (Hola et al., 2010; Hooton,
2010; Nicolle, 2005). Using standard culture methods, it
has been shown that most of the catheters are infected
by three or more microorganisms, and that only 12.5%
of the infections are monomicrobial (Hola et al., 2010).
Traditionally, the diagnosis of CAUTIs is based on
symptoms that patients present in combination with
microbiological culture of urine. Urine collected from
the catheter or from the bladder is cultured on agar
medium plates to detect the microorganisms involved
in the infection (Hooton, 2010; Nicolle, 2014a). The
infection is diagnosed when patients have a positive
urine culture of 105 CFU ml1 (104 CFU ml1 in chil-
dren) in association with other symptoms (e.g. dysuria,
urinary urgency, fever) (Burckhardt & Zimmermann,
2011). However, the microbiological culture of urine
from catheters might not reflect the microorganisms
present in the biofilm formed on the surface of the
catheter. In fact, microorganisms in biofilms have a dif-
ferent phenotype and behavior comparing with
the planktonic microorganisms present in urine.
Typically, biofilm populations grow slowly or poorly on
agar medium plates (Costerton, 2007). In addition, a
viable but nonculturable state of some microorganisms
and the antibiotic administration to prevent the infec-
tion might cause a false-negative result (Zimmerli et al.,
2004). Thus, to improve the recovery and the quantifica-
tion of the microorganisms attached to the urinary cath-
eter, methodologies based on sonication have been
recommended (Hola et al., 2010). As the microorgan-
isms attached extra- or intraluminally to the catheter
can be different, a sonication step before the culture
might allow the identification and quantification of
microbial population located on both the outer and
inner surface of the urinary catheter (Frank et al., 2009).
Then, the analysis of the microbial composition can be
performed by microscopy, cultivation or culture inde-
pendent techniques (Hoiby et al., 2015).
Recently, many culture-independent techniques
have been widely used to identify and quantify the
microbial diversity found on biofilm infection (Wolcott
et al., 2013). Previous studies (Davies et al., 2004;
Dowd et al., 2008; Guembe et al., 2012; Khot et al.,
2009; Price et al., 2009; Thomsen et al., 2010; Tuttle
et al., 2011) showed that some molecular techniques,
including the denaturant gradient gel electrophoresis
(DGGE), cloning, pyrosequencing, 16S ribosomal ribo-
nucleic acid (rRNA) gene polymerase chain reaction (PCR)
for bacteria or 18S and 28S rRNA PCR for fungi and ter-
minal restriction fragment length polymerase (TRFP)
seem to be more reliable to assess the microbiota present
in polymicrobial biofilms comparing with the conven-
tional culture methods. Using these techniques, it would
be likely that the 12.5% of monomicrobial infections
found by Hola et al. (2010) in long-term catheterization
could be even lower. In addition to the quantification of
diversity, microscopy analysis in combination with fluores-
cent in situ hybridization (FISH) has been used as a way
to locate microorganisms within the biofilm (e.g. Almeida
et al., 2011; Azevedo et al., 2015; Cerqueira et al., 2013;
Malic et al., 2009). FISH is based on phylogenetic markers
found in 16S or 23S rRNA sequences of microorganisms,
as ribosomes are particularly abundant and relatively sta-
ble in viable cells (Amann et al., 2001). While each urinary
catheter displays a unique biofilm community (Frank
et al., 2009), a list of the most prevalent microorganisms
that are recurrently recovered from urinary catheters is
presented in Figure 2. The European Center for Disease
Prevention and Control (ECDPC, 2015), in an annual epi-
demiological report from 2014, reported that the most
frequently isolated microorganisms were E. coli (28%),
Candida sp. (18%), Enterococcus sp. (17%), P. aeruginosa
(14%) and Klebsiella sp. (8%) (Figure 2(a)). Other studies
reported a clear prevalence of E. coli, P. aeruginosa,
E. faecalis and P. mirabilis (Hola & Ruzicka, 2011;
Matsukawa et al., 2005; Ohkawa et al., 1990). The anti-
microbial resistance of these microorganisms requires
attention due to the continuous use of antimicrobial
agents. In 2012, the ECDPC reported that the most com-
mon isolates from CAUTIs were resistant to, at least, one
of the antimicrobial agents used in clinical practice.
Among the most prevalent microorganisms, 26.3% of E.
coli isolates are resistant to third-generation cephalospor-
ins; 26.6% of P. aeruginosa isolates are resistant to ceftazi-
dime; and, 9.5% of Enterococcus sp. isolates are resistant
to vancomycin (ECDPC, 2015).
Other microorganisms less commonly found on poly-
microbial catheter biofilms, and designated here as
uncommon species, have also been isolated and identi-
fied (Figure 2(b)). The pathogenic potential of most of
these microorganisms remains poorly studied. The pres-
ence of these types of microorganisms in biofilm-associ-
ated infections has been reported not only for CAUTIs
(e.g. Frank et al., 2009; Hola et al., 2010; Xu et al., 2012),
but also for cystic fibrosis (e.g. Bittar et al., 2008; Coenye
et al., 2002). For example, in a study performed by Frank
et al. (2009), it was reported that the frequency in urin-
ary catheters-associated biofilms of D. tsuruhatensis and
A. xylosoxidans was 25% for each bacterium, while B.
fungorum was present in 13% of the samples. These
uncommon bacteria appeared in CAUTIs in combination
with well-established pathogenic bacteria such as E. coli,
K. pneumoniae and P. aeruginosa (Frank et al., 2009).
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The microbial interactions between uncommon and
pathogenic bacteria and how these types of bacteria
adapt to the urinary catheter niche and influence the
disease outcome remain unclear. Nonetheless, the
potential implication and contribution of these uncom-
mon bacteria in nosocomial human infections has been
receiving more attention (Azevedo et al., 2014, 2016;
Lopes et al., 2012, 2014, 2015).
Microbial ecology – microbial interactions
between microorganisms
Given that the outcome of a polymicrobial infection
depends on how microbial communities interact, the
research community rapidly recognized the urgency to
study polymicrobial biofilms.
When the interactions are antagonistic, at least one
of the microorganisms will be negatively affected by
the presence of another. Antagonistic microbial interac-
tions might be mediated by different mechanisms
(Figure 3(a)). In a competition relationship, microorgan-
isms may occupy the same niche and compete for
nutrients and physical resources (Faust & Raes, 2012;
Harrison, 2007; Rastall et al., 2005; Song et al., 2014).
Adding to this competition, microorganisms may
also produce toxins such as bacteriocins (Michel-Briand
& Baysse, 2002), that when secreted kill the other mem-
bers of the microbial community (Chang et al., 2005).
In this latter case, a microorganism might be able to
affect negatively the other without being affected by
the interaction.
Other mechanisms have been recently described
that, instead of releasing a toxin into the extracellular
space, require a close contact between cells in order for
the producer to be able to deliver the effector into the
target cell milieu. More specifically, a competition
mechanism, named type VI secretion system (T6SS),
found in Gram-negative bacterial species consists in
delivering proteins and toxins into a target cell in order
to kill all susceptible neighbors in a contact-dependent
manner (Filloux et al., 2008; Ho Brian et al., 2014; Hood
et al., 2010). The most important components of the
T6SS are the Hcp and VgrG, which assemble to form a
membrane puncturing device that resembles an
inverted phage tail and tube. It is thought that VgrG
forms the puncturing tip, while Hcp forms a contractile
tube. Together they make contact between the produ-
cer and the target cell membranes, delivering the T6SS
effectors (Alteri & Mobley, 2016).
Another mechanism dependent on cell-to-cell con-
tact, referred to as contact-dependent growth inhibition
(CDI) system, has also been described in bacteria (Ruhe
Figure 2. Microbial diversity found in catheter biofilms. (a) Percentages of the ten most frequently isolated microorganisms from
catheter-associated urinary tract infections; (b) List of some other microorganisms less frequently found in patients with catheter-
associated urinary tract infections (Choe et al., 2012; Hola et al., 2010; Hola & Ruzicka, 2011; Xu et al., 2012).
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et al., 2013; Willett et al., 2015). While CDI is widely dis-
tributed in Gram-negative bacteria, this mechanism
has also been identified in some Gram-positive bac-
teria (Braun & Patzer, 2013). CDI systems are com-
posed of the CdiA toxin secreted by CdiB (both part
of the Two-Partner Secretion system family), an outer
membrane b-barrel transporter, and an immunity
protein. CdiA exhibits a modular design consisting of
a very large and conserved N-terminal domain
exposed at the cell surface and acting as an adhe-
sin; and a shorter highly variable C-terminal domain
carrying toxin activity that is delivered into the
Figure 3. Schematic illustration of potential bacterial interactions within biofilm communities. (a) Antagonistic interactions among
bacteria might involve a competition for nutrients (I), of toxins that kill the neighboring members (II). (b) On the other hand, bac-
teria within biofilms might cooperate by producing cell-signaling molecules (III), matrix components (IV), public good metabolites
(V) and cross-feeding metabolites (VI). In addition, they might use different nutritional sources and in this case the fitness of one
species is not affected by the other (VII). These interactions result in the growth of bacteria within biofilms and polymicrobial bio-
film development with high resistance to stress conditions.
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cytoplasm of the recipient cell, causing cell inhibition
or death (Braun & Patzer, 2013).
While these mechanisms are understudied in biofilm
populations, their role on driving microbial ecology is
clear. For instance, there is evidence for transcriptional
regulation of the T6SS during biofilm formation, either
by promoting biofilm formation or by competing with
neighboring bacteria (Alteri & Mobley, 2016; Aubert
et al., 2008; Moscoso et al., 2011; Russell et al., 2014).
The same happens with CDI systems. They are involved
in adhesion and biofilm formation in different species,
such as E. coli, Burkholderia thailandensis and P. aerugi-
nosa (Anderson et al., 2012, 2014; Garcia et al., 2013;
Mercy et al., 2016; Ruhe et al., 2015). In fact, it has also
been shown that CDI might function in both coopera-
tive and competitive ways to build microbial commun-
ities with some type of kind-selective social behavior
(Anderson et al., 2014; Garcia et al., 2013; Ruhe et al.,
2015). While these works have provided valuable infor-
mation, studies into UTI related settings are inexistent
so far, which limits the transposition of this information
to the clinical field.
Regarding synergistic interactions, both microorgan-
isms might benefit from the presence of each other
(Figure 3(b)). This type of interaction might occur, for
instance, when the microorganisms cooperate in order
to increase the overall resistance to antimicrobial agents
of all members involved in a microbial community
(Rodrıguez-Martınez & Pascual, 2006). Another example
of this behavior occurs when two microorganisms
exchange metabolic products, known as the cross-feed-
ing phenomenon (Woyke et al., 2006). Metabolic
cooperation is an example observed when certain bac-
terial species modify the environmental conditions
within biofilms (e.g. pH, oxygen concentration) to favor
the growth of neighbors. For example, oxygen con-
sumption by aerobic microorganisms could be benefi-
cial for the growth of anaerobic microorganisms
(Stewart & Franklin, 2008).
In other situations, one of the microorganisms bene-
fits from the presence of another without affecting it.
An example of this behavior happens when one micro-
organism metabolizes a compound produced by other
community members (Faust & Raes, 2012) or receives a
plasmid carrying genes that promote antibiotic resist-
ance or virulence factors expression (Ghigo, 2001).
The increase of fitness of one member might also
occur at a cost of others (West et al., 2006). In particular,
secondary metabolites produced with a cost to microor-
ganisms might be used by neighboring members
(cheaters) of the biofilm without any cost (Xavier, 2011).
Examples, of this type of molecules, called “public
goods”, involve quorum sensing signaling molecules
(Diggle et al., 2007), iron scavenging siderophores
(Brockhurst et al., 2008; Cordero et al., 2012; Harrison &
Buckling, 2009; Jiricny et al., 2010) and antibiotic-deg-
radation enzymes (Ciofu et al., 2000; Dugatkin et al.,
2005). “Public goods” producers spend energy in its
production and the cheaters exploit the “public goods”
without cooperating; hence, cheaters are able to out-
compete the “public good” producers (Nadell et al.,
2009). For example, a group of bacteria might be able
to produce antibiotic-degrading enzymes that will help
all microbial members resist to antibiotic agents. This
phenomenon is crucial to the b-lactam antibiotics
inactivation in which the presence of b-lactamases in
the biofilms matrix might inactivate them (Ciofu et al.,
2000; Dugatkin et al., 2005; Gould et al., 2008).
Briefly, considering that the polymicrobial biofilms
exist in most human infections (Elias & Banin, 2012),
it is highly probable that the synergistic interactions
among microorganisms occur, enabling the coexist-
ence of microorganisms (Periasamy & Kolenbrander,
2009). In this way, inter-species cooperation increases
the fitness and the resistance of the whole biofilm
community even if any detrimental environmental con-
ditions occurs (Giaouris et al., 2015; Kara et al., 2006;
Luppens et al., 2008). In some situations, microorgan-
isms co-inhabit the same environment without inter-
acting (neutralism). For instance, microorganisms
might share the same space, but have different nutri-
tional requirements. Thus, the microorganisms live
together without any beneficial or harmful effect on
each other (Song et al., 2014).
Ecological perspective in the context of CAUTIs
polymicrobial communities
Most, if not all types of interactions described
above also occur under the context of CAUTIs (Table 2).
These interactions are very diverse, as the same species
present distinct behaviors when co-cultured with differ-
ent bacteria.
For instance, the in vitro study performed by
Cerqueira et al. (2013) has shown that despite E. coli
being the most prevalent causative agent of CAUTIs, it
turned out to be the less well-adapted to dual-species
biofilms, in contrast with P. aeruginosa that seemed to
persist better within the microbial consortia. By con-
trast, Croxall et al. (2011) demonstrated that E. coli from
polymicrobial UTI samples showed more resistance to
antibiotics and was more invasive in in vitro epithelial
cell infection studies. These are two good examples of
E. coli populations being “shaped” by the complex con-
sortium and surrounding microenvironment in which
they are inserted.
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The same happens for other UTI-associated species.
Antagonistic interactions between P. aeruginosa and P.
mirabilis were observed in urinary catheter biofilms
(Lehman & Donlan, 2015; Macleod & Stickler, 2007).
However, other studies have shown that the virulence
of P. aeruginosa and S. aureus biofilms is clearly stimu-
lated when both bacteria are grown in a consortium in
conditions mimicking CAUTIs (Goldsworthy, 2008).
Similar observations were made by Korgaonkar et al.
(2013) when it was demonstrated that the virulence of
P. aeruginosa was enhanced when co-cultured with
Gram-positive bacteria; for example, P. aeruginosa is
able to use peptidoglycan shed by Gram-positive bac-
teria to produce virulence factors with lytic functions.
However, in the context of cystic fibrosis, the interaction
between these two bacteria may be different.
Mashburn et al. (2005), Barnabie & Whiteley (2015)
reported that the presence of P. aeruginosa affects
negatively S. aureus; in fact, P. aeruginosa was able to
kill S. aureus to use the siderophores of this microorgan-
ism. These studies highlight the need for a tight control
of the biofilm conditions, as small changes might have
a great impact on ecological interactions. While mixed
biofilm studies in CAUTIs have mainly focused on
Table 2. Different types of potential microbial interactions described in the literature among pathogenic bacteria occurring in
CAUTIs.
Pathogen Experimental conditions Microbial interaction Explanation Refs.
E. coli with P. aeruginosa Six-well tissue culture plates
containing silicone coupons
immersed in AUM at 37 C
and 120 rpm
P. aeruginosa domi-
nated over E. coli
when co-cultured
E. coli presented lower growth
rate (0.20 h1) when com-
pared to P. aeruginosa
(0.30 h1) under the condi-
tions at which the biofilm
was formed.
Cerqueira et al., 2013
The extracellular production of
virulence factors by P. aerugi-
nosa, such as N-acyl-L-homo-
serine lactones, can
negatively regulate biofilm
formation by E. coli in mixed
biofilms.
P. aeruginosa with S. aureus Glass flow cells supplied with
a constant flow of AUM
(30ml h1) at 37 C
Virulence of P. aerugi-





Production of P. aeruginosa exo-
toxin A was increased nearly
2000-fold when P. aeruginosa
and S. aureus were grown in
a mixed biofilm.
Goldsworthy, 2008
P. mirabilis with M. morganii,
K. pneumoniae, E. coli, E.
cloacae or P. aeruginosa
Bladder model constituted by
a glass chamber main-
tained at 37 C. Silicone
catheters were inserted
into the chamber. The cath-
eter retention balloons
were inflated with 10ml
sterile water and the cathe-
ters were connected to
drainage bags. Sterile AUM
was pumped into the
chambers
Impact on the ability
of P. mirabilis to
encrust and block
urinary catheters
Co-infection of P. mirabilis with
M. morganii, K. pneumoniae
or E. coli had no effect on
the ability of P. mirabilis to
encrust and block catheters.
Co-infection with E. cloacae or P.
aeruginosa significantly
increased the time that cath-
eters took to block.
A pre-inoculation with E. cloa-
cae, M. morganii, K. pneumo-
niae or E. coli significantly
delayed catheter blockage.
However, P. mirabilis was
able to colonize the biofilms
and block the urinary
catheters.
Macleod & Stickler, 2007
P. mirabilis with P. stuartii Mice were inoculated with
50 lL of a 1:1 mixture of
both bacteria
High incidence of uro-
lithiasis and
bacteremia
Total urease activity was
increased during co-culture. A
synergistic induction of ure-
ase activity might explain in
part the high incidence of P.
mirabilis and P. stuartii in pol-
ymicrobial CAUTIs.
Armbruster et al., 2014
P. mirabilis with P. aeruginosa 96-well microplates in human




nosa and P. mirabilis
The elimination of P. aeruginosa
at 72 h was probably due to
the increase of pH between
48 and 72 h as a result of P.
mirabilis urease activity.
Lehman & Donlan, 2015
E. coli with P. mirabilis Mouse model of ascending
UTI
E. coli and P. mirabilis
do not directly com-
pete for nutrients
E. coli and P. mirabilis have dif-
ferent central metabolic path-
ways despite have access to
the same nutrients in the
urine.
Alteri et al., 2015
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bacterial interactions, a few studies have investigated
cross-kingdom interactions, especially between bacteria
and C. albicans species. For instance, C. albicans and E.
coli exhibit a cooperative interaction in UTI-related set-
tings. E. coli has proved to enhance adhesion of C. albi-
cans to the bladder mucosa, increasing the likelihood of
fungal urinary tract infections (Levison & Pitsakis, 1987).
de Padua et al. (2008) have also shown that P. aerugi-
nosa adhesion to urinary catheters is enhanced in the
presence of C. albicans, while C. albicans adhesion was
not significantly affected. This phenomenon was prob-
ably due to the P. aeruginosa selective attachment to
the fungus filamentous form (Hogan & Kolter, 2002). On
the other hand, it should be noticed that C. albicans–P.
aeruginosa biofilms have also been associated with
antagonistic interactions mainly due to the toxic effect
of some P. aeruginosa metabolites on C. albicans
(Morales et al., 2013). However, those observations were
not made on UTI-related settings. Candida–bacteria
interactions seem to be common in human-related bio-
films, especially with the oral or vaginal microflora (for a
review on Candida interactions with bacteria see
Morales & Hogan, 2010), but information on urinary
catheter-associated biofilm is limited and simulation of
biofilm real conditions is still poor or inexistent in the
majority of the studies. The complexity of interactions is
even higher when the factor “time” is taken into
account.
For instance, Macleod & Stickler (2007) reported that
any antagonistic effect of four other urinary tract patho-
gens (Enterobacter cloacae, Morganella morganii, E. coli
and K. pneumoniae) against P. mirabilis in catheter bio-
films is minimal and temporary.
Also, co-infection of P. mirabilis with E. cloacae or P.
aeruginosa significantly increased the time that cathe-
ters took to block (Macleod & Stickler, 2007).
Recent data have also suggested the importance of
studying bacterial metabolism during infection devel-
opment to better characterize the microbial interac-
tions (Alteri et al., 2009, 2015). In fact, bacterial
metabolism seems to contribute to the persistence and
pathogenesis of bacteria within biofilms as much as
their virulence abilities (Alteri et al., 2009). For instance,
the catabolism of amino acids present in urine gener-
ates tricarboxylic acid cycle (TCA; also known as citric
acid cycle or Krebs cycle) intermediates and gluconeo-
genesis substrates, allowing uropathogenic E. coli to
infect more efficiently the urinary tract (Alteri et al.,
2009). The TCA cycle involves a series of chemical reac-
tions used by all aerobic organisms to generate energy
through the oxidation of acetyl-CoA derived from car-
bohydrates, fats and proteins into carbon dioxide and
chemical energy in the form of guanosine triphosphate
(Kim et al., 2008). Gluconeogenesis is a metabolic path-
way that results in the production of glucose from cer-
tain non-carbohydrate carbon substrates such as lactic
acid, glycerol, glycine, serine, aspartate, and others
(Berg & Stryer, 2002). Based on this, a recent study ana-
lyzed the central metabolism of E. coli and P. mirabilis
to explain their ability to co-infect the same niche
(urinary tract). Firstly, it could be assumed that both
bacteria have the same nutritional preferences since
they colonize the same environment; however, results
showed that E. coli and P. mirabilis use different central
metabolic pathways despite having access to the same
nutrients in urine (e.g. amino acids, peptides and urea).
This suggests that co-infecting bacteria might not
necessarily compete for nutrients, hence increasing
their fitness during UTI development (Alteri et al.,
2015).
Altogether, these studies have focused on the ability
of pathogenic bacteria commonly found on biofilm
catheters to change their behavior when living in a con-
sortium. While all these studies have revealed some
aspects of interactions and persistence displayed by
known CAUTIs pathogens, the role of uncommon bac-
teria on CAUTIs development or the interactions
between uncommon bacteria and CAUTIs-associated
pathogenic bacteria is poorly described.
Potential role of uncommon bacteria over
pathogenesis of CAUTIs
In the literature, there are already some indications
about the possible contributions of uncommon micro-
organisms on the pathophysiology and on the anti-
microbial susceptibility pattern of biofilms-associated
with CAUTIs (Azevedo et al., 2016; Lopes et al., 2014).
Recently, it was reported that despite the unknown
pathogenic nature of D. tsuruhatensis and A. xylosoxi-
dans, they might interact synergistically with E. coli,
developing well-organized microbial consortia with
increased tolerance to several antibiotics commonly
prescribed in CAUTIs (Azevedo et al., 2016; Lopes et al.,
2014).
In addition, it was demonstrated that a residual con-
centration of uncommon bacteria was enough to con-
tribute to E. coli survival. The specific mechanism of this
shared protection is currently unknown; however, three
theories were proposed: (1) transfer of genetic material
from the uncommon bacteria to E. coli; (2) induction of
a different physiological state in the susceptible species
due to antibiotic uptake; (3) degradation of the anti-
biotic in the biofilm matrix, through the action of the
enzymes produced by uncommon bacteria. In this case,
uncommon bacteria have their metabolism directed to
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the secretion of b-lactamases and E. coli (the suscep-
tible cells) benefits from the action of the secreted
b-lactamases, predominating in the microbial
consortium.
In conclusion, these observations suggested that the
surface of urinary catheter and urine is a favorable habi-
tat for polymicrobial biofilms involving E. coli and
uncommon bacteria. In these conditions, E. coli and
uncommon bacteria, with a previous unrecognized role,
appear to be able to persist and survive, adjusting their
cell concentrations and metabolism to get maximum
benefits from living together. Even when outnumbered,
the presence of uncommon bacteria showed to have a
protective impact on the whole community. For
instance, this could be crucial if any stress condition
(e.g. use of antibiotic agents) occurs. Other possible
contributions of uncommon bacteria to the develop-
ment of CAUTIs can be found in Figure 4.
CAUTIs treatment – importance of shaping
polymicrobial interactions
New lessons in polymicrobial infections should be taken
into consideration, especially in the context of strat-
egies used for the treatment of CAUTIs. Currently, the
therapeutic strategies to prevent or treat CAUTIs involve
the use of renally excreted antibiotics in combination
with a periodic replacement of the urinary catheter. To
minimize the chances of a new re-infection, it is
recommended to replace the urinary catheter after 48 h
of antibiotic treatment (Wu et al., 2015).
Antibiotics (e.g. trimethoprim/sulfamethoxazole, nitro-
furantoin, ciprofloxacin, gentamicin, amoxicillin/clavulanic
acid) are administrated during 7 days in patients who
have relief of symptoms and 10–14 days for patients
who do not respond to the antibiotic therapy (Hooton,
2010). However, it has been described that bacterial
uropathogens isolated from patients with CAUTI or UTI
revealed high resistance to some antibiotic agents used
in clinical practice, such as ampicillin, trimethoprim
sulfamethoxazole, ciprofloxacin, amoxicillin/clavulanic
acid, and others (Croxall et al., 2011; Kazi et al., 2015;
Zhanel et al., 2000). In addition, if the urinary catheter is
not removed or replaced, re-infection can occur after
the end of an antibiotic treatment.
The different behavior of complex communities asso-
ciated with CAUTIs led scientists to speculate on their
ability to control biofilm by interfering on their species
composition; or on the possibility of anticipating the
possible clinical outcome based on the biofilm compos-
ition. An in vivo study performed by Armbruster et al.
(2014) showed that the co-infection of P. mirabilis and
P. stuartii, also a common co-colonizer of urinary cathe-
ters, resulted in a higher incidence of urolithiasis and
bacteremia due to an increased activity of total urease
(Armbruster et al., 2014). This might indicate that the
simultaneous presence of these species in CAUTI-associ-
ated biofilms represents an additional risk for the
Figure 4. Potential contribution of uncommon bacteria to a more stable polymicrobial biofilms development in CAUTIs. They
were observed in the studies found in literature (Azevedo et al., 2016; Lopes et al., 2014).
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patient. If this proves to be true, those clinical situations
should be handled with extra attention. Hence, it
becomes imperative that the clinicians know the biofilm
composition in order for a more adequate therapy
selection for an effective prevention or treatment of
infections.
Concluding remarks
Understanding how polymicrobial biofilm communities
behave and how uncommon bacteria and pathogenic
bacteria interact might have further implications in the
control and treatment of CAUTIs, since bacterial behav-
ior cannot be predicted from studies of single-species
biofilms. In addition, it is also important to note that
the role of uncommon bacteria is underestimated prob-
ably due to the absence of commercial media and kits
to detect these bacteria in hospitals.
The topic of this review raises several clinically-
relevant questions: Is the composition of a consortium
indicative of a potential harmful biofilm? Which anti-
biotic should be prescribed for a particular consortium?
The medical community has recognized the urgency to
better understand the clinical significance of species
involved in polymicrobial infections and how they
might affect the disease outcome. This could constitute
the basis for a new strategy in the control and treat-
ment of CAUTIs that uses the knowledge on the micro-
biome of each patient for a personalized therapy
selection.
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